Soleno Therapeutics Inc (SLNO)
Equity Ratio
81.49%
Quarterly · Period ending:
SLNO Equity Ratio
Latest reported81.49%period ending
Latest reported81.49%period ending
SLNO Quarterly Equity Ratio (-2386.38% → 81.49%)
Latest values, visible window
High-resolution chart · PNG
SLNO equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 81.494% | |
| 79.8317% | |
| 82.4819% | |
| 72.2647% | |
| 73.0169% | |
| 74.0585% | |
| 89.2126% | |
| 92.3145% | |
| 84.9257% | |
| 87.1693% | |
| 36.5393% | |
| 40.1564% | |
| 13.5091% | |
| 39.0535% | |
| 47.5312% | |
| 55.0935% | |
| 62.1939% | |
| 50.0464% | |
| 47.4639% | |
| 56.2487% | |
| 66.2505% | |
| 70.0917% | |
| 66.8756% | |
| 71.2373% | |
| 29.5239% | |
| 39.157% | |
| 51.819% | |
| 40.5549% | |
| 60.7997% | |
| 70.4804% | |
| 46.0678% | |
| 47.4958% | |
| 63.3591% | |
| 68.0005% | |
| 87.9767% | |
| 87.8444% | |
| 89.0123% | |
| 61.7302% | |
| 68.7447% | |
| 47.1545% | |
| 62.1299% | |
| 39.3091% | |
| -17.7141% | |
| -87.0239% | |
| -112.2777% | |
| -123.0667% | |
| -2,498.7028% | |
| -1,863.0776% | |
| -3,751.7964% | |
| -2,386.3791% |